Norepinephrine Reuptake Inhibitor [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Norepinephrine Reuptake Inhibitor [EPC] includes 2 drugs with a combined 10,052 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
10,052
Combined Reports
All Norepinephrine Reuptake Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| ATOMOXETINE | Atomoxetine | 9,199 | 1,373 | 1,834 | 14.9% |
| VILOXAZINE | QELBREE | 853 | 9 | 59 | 1.1% |
Common Side Effects in Norepinephrine Reuptake Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 14,139 | 885 |
| Nausea | 12,300 | 848 |
| Dizziness | 11,044 | 833 |
| Headache | 9,984 | 806 |
| Fatigue | 8,948 | 820 |
| Anxiety | 8,562 | 244 |
| Insomnia | 8,417 | 678 |
| Off label use | 8,302 | 1,211 |
| Drug withdrawal syndrome | 7,751 | 50 |
| Paraesthesia | 6,941 | 587 |